| Specific inhibition of Stat3 signal transduction by PIAS3 CD Chung, J Liao, B Liu, X Rao, P Jay, P Berta, K Shuai Science 278 (5344), 1803-1805, 1997 | 1407 | 1997 |
| Inhibition of Stat1-mediated gene activation by PIAS1 B Liu, J Liao, X Rao, SA Kushner, CD Chung, DD Chang, KE Shuai Proceedings of the National Academy of Sciences 95 (18), 10626-10631, 1998 | 1023 | 1998 |
| Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate MG Sanna, J Liao, E Jo, C Alfonso, MY Ahn, MS Peterson, B Webb, ... Journal of Biological Chemistry 279 (14), 13839-13848, 2004 | 727 | 2004 |
| Glucagon-like peptide-1 and its class BG protein–coupled receptors: a long march to therapeutic successes C De Graaf, D Donnelly, D Wootten, J Lau, PM Sexton, LJ Miller, JM Ahn, ... Pharmacological reviews 68 (4), 954-1013, 2016 | 304 | 2016 |
| mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells J Zhou, P Su, L Wang, J Chen, M Zimmermann, O Genbacev, O Afonja, ... Proceedings of the national academy of sciences 106 (19), 7840-7845, 2009 | 230 | 2009 |
| A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice D Chen, J Liao, N Li, C Zhou, Q Liu, G Wang, R Zhang, S Zhang, L Lin, ... Proceedings of the National Academy of Sciences 104 (3), 943-948, 2007 | 220 | 2007 |
| Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1 K Shuai, J Liao, MM Song Molecular and cellular biology 16 (9), 4932-4941, 1996 | 187 | 1996 |
| Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in … J Liao, Y Fu, K Shuai Proceedings of the National Academy of Sciences 97 (10), 5267-5272, 2000 | 177 | 2000 |
| Development of FRET assay into quantitative and high-throughput screening technology platforms for protein–protein interactions Y Song, V Madahar, J Liao Annals of biomedical engineering 39, 1224-1234, 2011 | 133 | 2011 |
| Chemistry and biology of sphingolipids J Liao, J Tao, G Lin, D Liu Tetrahedron 61 (20), 4715-4733, 2005 | 130 | 2005 |
| Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis J Tan, SH Hall, KG Hamil, G Grossman, P Petrusz, J Liao, K Shuai, ... Molecular Endocrinology 14 (1), 14-26, 2000 | 117 | 2000 |
| Development of an early-warning system for high-risk patients for suicide attempt using deep learning and electronic health records L Zheng, O Wang, S Hao, C Ye, M Liu, M Xia, AN Sabo, L Markovic, ... Translational psychiatry 10 (1), 72, 2020 | 80 | 2020 |
| Three sweet receptor genes are clustered in human chromosome 1 J Liao, PG Schultz Mammalian genome 14, 291-301, 2003 | 73 | 2003 |
| Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice M He, H Su, W Gao, SM Johansson, Q Liu, X Wu, J Liao, AA Young, ... PloS one 5 (12), e14205, 2010 | 69 | 2010 |
| Sphingosine 1-phosphate pathway therapeutics: a lipid ligand–receptor paradigm H Rosen, J Liao Current opinion in chemical biology 7 (4), 461-468, 2003 | 64 | 2003 |
| Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor Q Liu, N Li, Y Yuan, H Lu, X Wu, C Zhou, M He, H Su, M Zhang, J Wang, ... Journal of medicinal chemistry 55 (1), 250-267, 2012 | 58 | 2012 |
| Boc5, a non-peptidic glucagon-like peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic mice H Su, M He, H Li, Q Liu, J Wang, Y Wang, W Gao, L Zhou, J Liao, ... PloS one 3 (8), e2892, 2008 | 56 | 2008 |
| Protein interaction affinity determination by quantitative FRET technology Y Song, VGJ Rodgers, JS Schultz, J Liao Biotechnology and bioengineering 109 (11), 2875-2883, 2012 | 49 | 2012 |
| Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study D Mo, S Liu, H Ma, H Tian, H Yu, X Zhang, N Tong, J Liao, Y Ren Drug design, development and therapy, 2769-2776, 2019 | 44 | 2019 |
| Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators J Liao, Y Hong, Y Wang, TW Von Geldern, KE Zhang US Patent 8,748,412, 2014 | 42 | 2014 |
Ming-Wei WangChinese Academy of Sciences/Fudan UniversityVerified email at simm.ac.cn
